Login to Your Account



Washington Roundup

Value of Gene-Based Patents in the Eye of the Beholder

By Mari Serebrov
Washington Editor

Friday, January 11, 2013
The only thing that was clear in a roundtable discussion the Patent and Trademark Office (PTO) held Thursday on gene-based diagnostics is that a consensus on the value of patents for the diagnostics, and DNA in general, is as out of reach as ever.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription